- Multiple-low-dose therapy: effective killing of high-grade serous ovarian cancer cells with ATR and CHK1 inhibitors.
- Golder A, Nelson L, Tighe A, Barnes B, Coulson-Gilmer C, Morgan RD, McGrail JC, Taylor SS.
- NAR Cancer. 2022 Nov 12;4(4):zcac036. doi: 10.1093/narcan/zcac036.
- PMID: 36381271
- PubMed abstract